HCPLive
According to the American Society of Nephrology, Kidney Week 2012 is “the world's premier nephrology meeting. More than 13,000 kidney professionals from around the globe will come together to exchange knowledge, learn the latest scientific and medical advances, and listen to engaging and provocative exchanges between leading experts in the field.”
Kidney Week 2012

Kidney Week 2012 | KW 2012

Conference Coverages

Study Shows Regional Variations in Dialysis Initiation among ESRD Patients
Study Shows Regional Variations in Dialysis Initiation among ESRD Patients
Patients with end-stage renal disease who live in the Midwest begin dialysis at an earlier stage than patients who live in other regions of the US.
Study Shows Tolvaptan is Effective in Treating Autosomal Dominant Polycystic Kidney Disease
Results from the TEMPO trial presented at Kidney Week 2012 show that treatment with tolvaptan slowed the increase in total kidney volume and the decline in kidney function in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD).
New Research Paradigms Needed for Chronic Kidney Disease
Randomized controlled trials remain the gold standard, but a researcher at Kidney Week 2012 says that new approaches and study designs are needed that reflect real-world drug use and account for confounding variables.
Treatment Options for Patients with Hyponatremia
Experts at Kidney Week 2012 discuss several treatment options for hyponatremia, including fluid restriction, loop diuretics, and the use of selective vasopressin V2-receptor antagonists.
Dietary-based Approaches to Treating Metabolic Acidosis in Patients with Chronic Kidney Disease
A diet rich in highly alkaline fruits and vegetables helps reduce a marker of kidney injury and preserve kidney function in patients with chronic kidney disease.
Exploring the Future of Prediabetic Living Kidney Donors
Increasing numbers of people are on kidney transplant waiting lists. However, the number of potential living donors may shrink as more Americans qualify as pre-diabetic, making them less than ideal donor candidates.
Reducing the Risk of Rejection Following Kidney Transplant in Patients with End-stage Renal Disease
The powerful immunosuppressive drugs used to prevent allograft rejection are associated with severe side effects. A “mixed chimerism” strategy in which patients undergo simultaneous bone marrow and kidney transplant from the same donor may improve transplant survival and reduce the need for these drugs.

Most Popular

$vacMongoViewPlus$ $vAR$